We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Initiating a patent protection strategy?! Well yes, patent protection is a good idea if you’re an IP based company. Almost no detail whatsoever about how they plan to do it. Strange and bizarre communication.
Maybe thats what the potential partners want before they seal the deal.
Remember we going for 2 indications with this drug.
Back to work for me after 2 weeks off.
Gla
They have discussions with a deal looks like.
He he he he.
Quite close Nolupus or should I say Tim ?
Yes but for good reason, extending patent life suggests the company and its backers expect the next Phase 3 trial to produce results.
UP WE GO
Hope everyone had a nice relaxing BH and Easter
Frits. Everyone is entitled to an opinion. Nolupus makes a valid point.
Nobinpus,
By your own admission, you have stated several times that you are not invested in IMM! Stop changing the story to suit your negative passive aggressive narrative.
Frits
Wildbunch,
They may be awaiting on some patent news before concluding any major deal..
Let's wait and see
Absolutely agree with you wildbunch.
Thats the transparency we need and deserve as shareholders.
Gla
I think that we need more information about the Lupus trial timetable. This will help negotiations for the ROTW rights. Also orphan status etc for CIDP.
As a side issue INC alone could be worth circa 5p in the shortish term.
Look forward to seeing more investors at this AGM.
GLA
GLA
Absolute bargain, but dont you just get tje feeling that it will pop 🤣🎊
....£M9.16. Still laughable. A great BUY.
Regardless, we want IMM to be successful because we want to improve the quality of life of our patients.
Gla
Nolupus
Both-actually I am going to stop wasting my time looking at your posts. Same old-same old.
Goodbye and best of luck with any investments you have.
Wildbunch.
It's Always important to check things for yourself ..
By the way is Tim Ceo or Chairman ?
Just checking ..
Nolupus
Nolupus
I like facts to be accurate-I was surprised by 2018 so I checked-then asked you in case I had missed something. Had similar exchange with Dale recently.
Wildbunch,
Correct 2019 , does that make a huge difference ?
Not really
Nolupus
I may be wrong but wasn't the Agreement with Avion signed in November 2019?
Wildbunch,
I mentioned that the CEO's stake IS much less in IMM than his Chairman's stake in Incanthera but thats his business and is public knowledge. (due to the FCA Rules)
I have no intention of even considering any form of dissention against the CEO as that would be quitte a waste of time imo
Personaly, i would and expect him to move forward swiftly with IMM's main objective which one should remember IS bringing IMM's science to the market place ( the deal with Avion for a New P3 trial dates back to 2018 ) and yet lupus patients are still waiting waiting and AGAIN waiting
Whilst some people may want to feel the need to show their portfolio to others , i have Always preferred to keep mine to myself
P.s. Everyone to their own trades and convictions
Given the restructuring and strong portfolio, doesnt matter which way you look at it, the Company is undervalued and we will reap the fruit, buying in at this level is the bottom imo.
Gl
Agreed with that 2 million that stinks since that happen imm was doomed . A lot here HAVE SELECTIVE MEMORY
A Very Very Very Strong Buy, Strongest Buy I have seen in many years, In fact, if it gets any stronger, it can take over superman’s job..
He has absolutely zero shares,
Nada,
Zilch,
Nowt,
Not a bolt,
Nothing...
Did I miss any? Please chip in if I have...
He calls Tim our CEO! how is he your CEO when your has absolutely zero capital invested in this company. You write as if you have zillions of stock in this company and you have nothing.
Your just some kind of Walter Mitty who pretends he is invested!!
So, until you do have some skin in the game...
Zip it.,
leave this to the BIG Boys and Girls who do have a say in IMM, we have no time for petulant children who are playing play pretend.
I would book an appointment toot sweet.
Frits
Nolupus,
Contrarianism is good. I am a firm adept.
It has served me well with GLEN in 2015 and superbly with INDV in 2018 and MRO in 2020/22. For balance, IRV in 2018 is best forgotten, that was very painful!
May the luck continue here with IMM.
Best,
🐸